DVAX
Price
$10.31
Change
-$0.34 (-3.19%)
Updated
Apr 17 closing price
Capitalization
1.62B
11 days until earnings call
IRWD
Price
$0.73
Change
-$0.02 (-2.67%)
Updated
Apr 17 closing price
Capitalization
1.36B
11 days until earnings call
Ad is loading...

DVAX vs IRWD

Header iconDVAX vs IRWD Comparison
Open Charts DVAX vs IRWDBanner chart's image
Dynavax Technologies
Price$10.31
Change-$0.34 (-3.19%)
Volume$2.95M
Capitalization1.62B
Ironwood Pharmaceuticals
Price$0.73
Change-$0.02 (-2.67%)
Volume$3.33M
Capitalization1.36B
DVAX vs IRWD Comparison Chart
Loading...
DVAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IRWD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DVAX vs. IRWD commentary
Apr 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DVAX is a Hold and IRWD is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 20, 2025
Stock price -- (DVAX: $10.31 vs. IRWD: $0.73)
Brand notoriety: DVAX and IRWD are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: DVAX: 109% vs. IRWD: 96%
Market capitalization -- DVAX: $1.62B vs. IRWD: $1.36B
DVAX [@Pharmaceuticals: Other] is valued at $1.62B. IRWD’s [@Pharmaceuticals: Other] market capitalization is $1.36B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DVAX’s FA Score shows that 0 FA rating(s) are green whileIRWD’s FA Score has 1 green FA rating(s).

  • DVAX’s FA Score: 0 green, 5 red.
  • IRWD’s FA Score: 1 green, 4 red.
According to our system of comparison, IRWD is a better buy in the long-term than DVAX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DVAX’s TA Score shows that 4 TA indicator(s) are bullish while IRWD’s TA Score has 4 bullish TA indicator(s).

  • DVAX’s TA Score: 4 bullish, 6 bearish.
  • IRWD’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, IRWD is a better buy in the short-term than DVAX.

Price Growth

DVAX (@Pharmaceuticals: Other) experienced а -6.02% price change this week, while IRWD (@Pharmaceuticals: Other) price change was -28.05% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +3.78%. For the same industry, the average monthly price growth was -5.82%, and the average quarterly price growth was -13.07%.

Reported Earning Dates

DVAX is expected to report earnings on Jul 31, 2025.

IRWD is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+3.78% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DVAX($1.62B) has a higher market cap than IRWD($1.36B). DVAX has higher P/E ratio than IRWD: DVAX (31.63) vs IRWD (10.31). DVAX YTD gains are higher at: -19.264 vs. IRWD (-83.596). DVAX has higher annual earnings (EBITDA): 9.67M vs. IRWD (-924.84M). DVAX has more cash in the bank: 742M vs. IRWD (92.2M). DVAX has less debt than IRWD: DVAX (257M) vs IRWD (716M). IRWD has higher revenues than DVAX: IRWD (443M) vs DVAX (232M).
DVAXIRWDDVAX / IRWD
Capitalization1.62B1.36B119%
EBITDA9.67M-924.84M-1%
Gain YTD-19.264-83.59623%
P/E Ratio31.6310.31307%
Revenue232M443M52%
Total Cash742M92.2M805%
Total Debt257M716M36%
FUNDAMENTALS RATINGS
DVAX vs IRWD: Fundamental Ratings
DVAX
IRWD
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
70
Overvalued
74
Overvalued
PROFIT vs RISK RATING
1..100
56100
SMR RATING
1..100
84100
PRICE GROWTH RATING
1..100
8198
P/E GROWTH RATING
1..100
9714
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

DVAX's Valuation (70) in the Biotechnology industry is in the same range as IRWD (74) in the Pharmaceuticals Other industry. This means that DVAX’s stock grew similarly to IRWD’s over the last 12 months.

DVAX's Profit vs Risk Rating (56) in the Biotechnology industry is somewhat better than the same rating for IRWD (100) in the Pharmaceuticals Other industry. This means that DVAX’s stock grew somewhat faster than IRWD’s over the last 12 months.

DVAX's SMR Rating (84) in the Biotechnology industry is in the same range as IRWD (100) in the Pharmaceuticals Other industry. This means that DVAX’s stock grew similarly to IRWD’s over the last 12 months.

DVAX's Price Growth Rating (81) in the Biotechnology industry is in the same range as IRWD (98) in the Pharmaceuticals Other industry. This means that DVAX’s stock grew similarly to IRWD’s over the last 12 months.

IRWD's P/E Growth Rating (14) in the Pharmaceuticals Other industry is significantly better than the same rating for DVAX (97) in the Biotechnology industry. This means that IRWD’s stock grew significantly faster than DVAX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DVAXIRWD
RSI
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 4 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 4 days ago
80%
Momentum
ODDS (%)
Bearish Trend 4 days ago
73%
Bearish Trend 4 days ago
85%
MACD
ODDS (%)
Bearish Trend 7 days ago
70%
Bearish Trend 4 days ago
74%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
77%
Bearish Trend 4 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
76%
Bearish Trend 4 days ago
79%
Advances
ODDS (%)
Bullish Trend 7 days ago
77%
Bullish Trend 5 days ago
66%
Declines
ODDS (%)
Bearish Trend 4 days ago
79%
Bearish Trend 7 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
69%
Bullish Trend 4 days ago
76%
Aroon
ODDS (%)
Bearish Trend 4 days ago
76%
Bearish Trend 4 days ago
77%
View a ticker or compare two or three
Ad is loading...
DVAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IRWD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME26.780.53
+2.02%
GameStop Corp
AAPL196.982.71
+1.39%
Apple
BTC.X85063.414000612.609400
+0.73%
Bitcoin cryptocurrency
SPY525.66N/A
N/A
SPDR® S&P 500® ETF
TSLA241.37-0.18
-0.07%
Tesla

DVAX and

Correlation & Price change

A.I.dvisor indicates that over the last year, DVAX has been loosely correlated with SUPN. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if DVAX jumps, then SUPN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DVAX
1D Price
Change %
DVAX100%
-3.19%
SUPN - DVAX
34%
Loosely correlated
+0.16%
ALKS - DVAX
33%
Poorly correlated
-0.74%
ETON - DVAX
29%
Poorly correlated
+1.85%
AMPH - DVAX
28%
Poorly correlated
+1.57%
ESPR - DVAX
28%
Poorly correlated
N/A
More

IRWD and

Correlation & Price change

A.I.dvisor tells us that IRWD and BGPPF have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IRWD and BGPPF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IRWD
1D Price
Change %
IRWD100%
-3.11%
BGPPF - IRWD
24%
Poorly correlated
N/A
AMPH - IRWD
23%
Poorly correlated
+1.57%
DVAX - IRWD
22%
Poorly correlated
-3.19%
HKMPF - IRWD
22%
Poorly correlated
N/A
EOLS - IRWD
22%
Poorly correlated
+6.73%
More